WallStreetZenWallStreetZen

NASDAQ: SABS
Sab Biotherapeutics Inc Stock Ownership - Who owns Sab Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sab Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew MoinDirector2025-09-291,740,000$1.75
$3.05MBuy
Sessa Capital Master LPDirector2025-09-291,740,000$1.75
$3.05MBuy

1 of 1

SABS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SABS insiders and whales buy or sell their stock.

SABS Shareholders

What type of owners hold Sab Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital LLC23.99%11,420,000$50.13MInstitution
Christine E. Hamilton23.61%11,237,694$49.33MInsider
Edward D. Hamilton21.06%10,023,848$44.00MInsider
Andrew Moin14.25%6,783,028$29.78MInsider
Ilan Katz12.81%6,097,150$26.77MInsider
Eddie Joe Sullivan10.99%5,232,304$22.97MInsider
Ra Capital Management LP9.25%4,401,500$19.32MInstitution
Commodore Capital LP9.25%4,401,500$19.32MInstitution
Samuel J. Reich8.01%3,814,524$16.75MInsider
Big Cypress Holdings LLC6.40%3,047,825$13.38MInsider

1 of 3

SABS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SABS35.08%64.92%Net Buying
NVCT14.42%43.61%Net BuyingNet Buying
ALEC61.21%38.79%Net SellingNet Selling
ARCT87.51%12.49%Net Buying
FENC3.88%96.12%Net SellingNet Selling
View Top Biotech Stocks

Sab Biotherapeutics Stock Ownership FAQ

Who owns Sab Biotherapeutics?

Sab Biotherapeutics (NASDAQ: SABS) is owned by 58.87% institutional shareholders, 108.92% Sab Biotherapeutics insiders, and 0.00% retail investors. Christine E. Hamilton is the largest individual Sab Biotherapeutics shareholder, owning 11.24M shares representing 23.61% of the company. Christine E. Hamilton's Sab Biotherapeutics shares are currently valued at $49.33M.

If you're new to stock investing, here's how to buy Sab Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.